Clinical Trial Results:
A multicentre randomised, placebo-controlled, double-blind pivotal clinical trial for the evaluation of safety and efficacy of specific of immunotherapy with an aluminium hydroxide-adsorbed hypoallergenic recombinant derivative of the major birch pollen allergen, rBet v1-FV
Summary
|
|
EudraCT number |
2007-001029-84 |
Trial protocol |
DE SE FI |
Global completion date |
18 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Nov 2016
|
First version publication date |
10 Nov 2016
|
Other versions |
|
Summary report(s) |
0702 DBP final version_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.